Skip to content

Asset Entities ASST Medical Device — Nonoperating Income (Expense)

Similar metrics at other companies

Apollo Global Management logo
APOAsset Management — Nonoperating Income (Expense)
-$97M-288%
Abbott logo
ABTMedical Devices — Operating Earnings
$1.89B+17.7%
Becton, Dickinson and Company logo
BDXMedical — Other Operating Income
$4.25M+950%
Burford Capital logo
BURAsset Management and Other Services — Nonoperating Income (Expense)
$543K
Johnson & Johnson logo
JNJMedical Devices — Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
$1.24B-12.8%
ITG
ITGRReportable Segment — Other Nonoperating Income (Expense)
-$13.3M-1,411%

Other financials

Income statement

See full
Revenue$2.8M+1,516%
Operating income-$313.1M-7,588%
Net income-$265.9M-6,993%
EPS (diluted)-$4.53-175%

Balance sheet

See full
Cash & equivalents$95.1M+982%
Total debt$3.4M
Total equity$714.8M+3,548%
Total assets$1.1B+21,931%

Cash flow

See full
Operating cash flow-$31.0M-455%
CapEx--100%
Free cash flow-$31.0M-450%

Valuation

See full
Market cap$1.02B+1,127%
Enterprise value$932M
P/S118.1×

Profitability

See full
Operating margin-6,563%-18,545pp
Net margin-8,022.9%-20,291pp
FCF margin-3,856.7%

Returns & leverage

See full
Return on equity-189.4%+139pp
Debt / equity
Current ratio11.4×+1.7×

Where this comes from

Reported directly by Asset Entities in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Asset Entities’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Asset Entities's medical device — nonoperating income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Asset Entities's medical device — nonoperating income (expense)?
Asset Entities (ASST) reported medical device — nonoperating income (expense) of $205K in Q1 2026.
What does medical device — nonoperating income (expense) mean?
Captures financial results from activities outside the core medical device operations, such as investment income, currency fluctuations, or one-time charges. It provides a clearer view of the segment's underlying operational performance by isolating non-core items.